![IHC-P analysis of human thyroid gland tissue using GTX04455 CDH16 antibody [MSVA-516R] HistoMAX?.<br>Strong membranous CDH16 staining of follicle cells CDH16 immunohistochemistry.](/domestic/data/graphics/GNT/graphics/GTX04455_20230728_IHC-P_265_23072723_346_s.jpg)
IHC-P analysis of human thyroid gland tissue using GTX04455 CDH16 antibody [MSVA-516R] HistoMAX?.
Strong membranous CDH16 staining of follicle cells CDH16 immunohistochemistry.
![IHC-P analysis of human thyroid carcinoma tissue using GTX04455 CDH16 antibody [MSVA-516R] HistoMAX?.<br>CDH16 negative papillary carcinoma invading CDH16 positive normal thyroid CDH16 immunohistochemistry.](/domestic/data/graphics/GNT/graphics/GTX04455_20230728_IHC-P_5_23072722_121_s.jpg)
IHC-P analysis of human thyroid carcinoma tissue using GTX04455 CDH16 antibody [MSVA-516R] HistoMAX?.
CDH16 negative papillary carcinoma invading CDH16 positive normal thyroid CDH16 immunohistochemistry.
![IHC-P analysis of human chromophobe renal cell carcinoma (ChRCC) from kidney tissue using GTX04455 CDH16 antibody [MSVA-516R] HistoMAX?.<br>Chromophobe renal cell carcinoma with strong CDH16 immunostaining of tumor cells CDH16 immunohistochemistry.](/domestic/data/graphics/GNT/graphics/GTX04455_20230728_IHC-P_135_23072722_752_s.jpg)
IHC-P analysis of human chromophobe renal cell carcinoma (ChRCC) from kidney tissue using GTX04455 CDH16 antibody [MSVA-516R] HistoMAX?.
Chromophobe renal cell carcinoma with strong CDH16 immunostaining of tumor cells CDH16 immunohistochemistry.